Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Nov;15(11):1415-1418.
doi: 10.25122/jml-2021-0316.

Protein C and S levels in patients with Thalassemia intermedia

Nawsherwan Sadiq Mohammed  1
Affiliations

Protein C and S levels in patients with Thalassemia intermedia

Nawsherwan Sadiq Mohammed. J Med Life. 2022 Nov.

Abstract

This study was conducted to assess the level of proteins C and S in patients with thalassemia intermedia from the Thalassemia Center in Erbil, Iraq. This study aimed to evaluate protein C and S levels in patients with β-thalassemia intermedia and correlate them to different clinical and laboratory parameters. This comprehensive descriptive case-control study was conducted in 2021. Twenty-three thalassemia intermedia patients were recruited. After the participants' demographic data were recorded, plasma levels of both proteins were measured. The acquired files were examined for the 23 patients studied, 48% of whom were female. The mean age of the patients was 16.32 years. The findings show that the proportion of protein C in males was greater than in females, while this percentage contrasts when compared with protein S (ranging between 89-99% and 85-96%, respectively). Concerning age, these two types of protein in children have more value compared to older ages. Only seven people had less than 1,000 ferritins, while the others had higher values. A decrease in proteins C and S was observed in the thalassemia intermediate compared to the control group. There was a significant relationship between the decreased protein C and S levels with splenectomy. Given the significant reduction in protein C and S levels among patients with thalassemia intermediate compared to the control group, there is an increased risk of thromboembolic events in patients with thalassemia intermediate.

Keywords: protein C; protein S; thalassemia; thromboembolic events.

PubMed Disclaimer

Conflict of interest statement

The author declares no conflict of interest.

Figures

Figure 1A
Figure 1A
Normal and below normal protein C levels in patients and control group.
Figure 1B
Figure 1B
Normal and below normal protein S levels in patients and control group.
See this image and copyright information in PMC

References

    1. Kosaryan M, Vahidshahi K, Karami H, Forootan MA, Ahangari M. Survival of thalassemic patients referred to the Boo Ali Sina Teaching Hospital, Sari, Iran. Hemoglobin. 2007;31(4):453–62. doi: 10.1080/03630260701641294. - DOI - PubMed
    1. Dennis LK, Eugene B, Anthony FS, Stephen H, Harrison l. Internal Medicine. 16th Edn Edwar, New York ISBN-1 0: 0071402357. 2005:593-601.
    1. Moratelli S, De Sanctis V, Gemmati D, Serino ML, Mari R, Gamberini MR, Scapoli GL. Thrombotic risk in thalassemic patients. J Pediatr Endocrinol Metab. 1998;11(Suppl 3):915–21. - PubMed
    1. Isma'eel H, Arnaout MS, Shamseddeen W, Mahfouz R, et al. Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients. J Thromb Thrombolysis. 2006 Oct;22(2):121–3. doi: 10.1007/s11239-006-8953-3. - DOI - PubMed
    1. Eldor A, Durst R, Hy-Am E, Goldfarb A, et al. A chronic hypercoagulable state in patients with beta-thalassaemia major is already present in childhood. Br J Haematol. 1999 Dec;107(4):739–46. doi: 10.1046/j.1365-2141.1999.01758.x. - DOI - PubMed

LinkOut - more resources